These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26871268)

  • 1. A service evaluation comparing CVVH an CVVHD in minimising circuit failure.
    Ede J; Dale A
    Nurs Crit Care; 2017 Jan; 22(1):52-57. PubMed ID: 26871268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M; Tiula E; Backman JT; Neuvonen PJ
    J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Blood Flow Continuous Veno-Venous Haemodialysis Compared with Higher Blood Flow Continuous Veno-Venous Haemodiafiltration: Effect on Alarm Rates, Filter Life, and Azotaemic Control.
    Sansom B; Sriram S; Presneill J; Bellomo R
    Blood Purif; 2022; 51(2):130-137. PubMed ID: 34010832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veno-venous continuous renal replacement therapy for burned patients with acute renal failure.
    Tremblay R; Ethier J; Quérin S; Béroniade V; Falardeau P; Leblanc M
    Burns; 2000 Nov; 26(7):638-43. PubMed ID: 10925188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients.
    Meisner M; Hüttemann E; Lohs T; Kasakov L; Reinhart K
    Eur J Anaesthesiol; 2000 Nov; 17(11):665-71. PubMed ID: 11029564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous haemofiltration and haemodiafiltration for acute renal failure in severely burned patients.
    Leblanc M; Thibeault Y; Quérin S
    Burns; 1997 Mar; 23(2):160-5. PubMed ID: 9177886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with Omni®.
    Whiting L; Bianchi NA; Alouazen K; Joannes-Boyau O; Chiche JD; Schneider A
    Blood Purif; 2022; 51(12):1039-1047. PubMed ID: 35636389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis.
    Brain M; Winson E; Roodenburg O; McNeil J
    BMC Nephrol; 2017 Feb; 18(1):69. PubMed ID: 28219324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.
    Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Brüggemann RJ; Lefrant JY; Roberts JA
    Clin Pharmacokinet; 2017 Sep; 56(9):1057-1068. PubMed ID: 28035589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ammonia Clearance with Different Continuous Renal Replacement Therapy Techniques in Patients with Liver Failure.
    Fisher C; Baldwin I; Fealy N; Naorungroj T; Bellomo R
    Blood Purif; 2022; 51(10):840-846. PubMed ID: 35042216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing hypothermia during continuous veno-venous haemodiafiltration: a randomized controlled trial.
    Rickard CM; Couchman BA; Hughes M; McGrail MR
    J Adv Nurs; 2004 Aug; 47(4):393-400. PubMed ID: 15271158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inadvertent sodium loading with renal replacement therapy in critically ill patients.
    Bihari S; Taylor S; Bersten AD
    J Nephrol; 2014 Aug; 27(4):439-44. PubMed ID: 24493390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey.
    RENAL Study Investigators
    Crit Care Resusc; 2008 Sep; 10(3):225-30. PubMed ID: 18798721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Evaluation of Continuous Veno-venous Hemodiafiltration and Continuous Arterio-Venous Hemodiafiltration in Patients of Hepatic Failure and / or Hepatorenal Syndrome.
    Nand N; Verma P; Jain D
    J Assoc Physicians India; 2019 Aug; 67(8):39-42. PubMed ID: 31562715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous haemofiltration and/or haemodiafiltration.
    Davenport A
    Contrib Nephrol; 2004; 144():317-28. PubMed ID: 15264420
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration.
    Fealy N; Baldwin I; Bellomo R
    Crit Care Resusc; 2002 Dec; 4(4):266-70. PubMed ID: 16573439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltration.
    Leslie GD; Jacobs IG; Clarke GM
    Intensive Care Med; 1996 Nov; 22(11):1261-4. PubMed ID: 9120123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.